Another study revealed that miR-221/222 released from TAM-MCF-7 could enter wild-type MCF-7 cells, endowing them with tamoxifen and fulvestrant refractoriness via p27 and ERα modulation, thereby enabling tumor growth in an ER-independent manner. The gene discussed is ESR1; the disease is neoplasm.